INTRODUCTION
B cells are known for their capacity to produce antibodies and to stimulate helper T cells as antigen-presenting cells (APCs) (1) , and these B cells are commonly referred to as conventional B cells or B-2 cells. However, some unique B cell subsets can suppress various immune responses. Katz and co-workers (2) were the first to demonstrate that the delayed-type hypersensitivity reaction was aggravated by the depletion of B cells. After 30 years, Mizoguchi and Bhan (3) introduced the term regulatory B (B reg ) cells to designate negative regulatory B cell subsets. Subsequently, many studies have reported that B reg cells suppress various immune disorders, such as collageninduced arthritis, experimental autoimmune encephalomyelitis, contact hypersensitivity (CHS), and colitis (4) . Although the inhibitory mechanism of B reg cells is mostly interleukin-10 (IL-10) dependent, B reg cells can also regulate the immune response by secreting transforming growth factor- (TGF-) or IL-35. TGF- + CD5 + B cells induce the development of Foxp3 + regulatory T (T reg ) cells to suppress allergic airway inflammation (5) . IL-35 secreted by B reg cells not only inhibited T helper cell 1 (T H 1)/T H 17 immunity but also increased the population of T reg cells to inhibit experimental autoimmune uveitis (4) . The knockout of IL-35 in B cells also resulted in enhanced T H 1 cell responses in autoimmune and infectious diseases (6) . In another mechanism, programmed death-ligand 1 (PD-L1) hi B cells inhibited the development of follicular T cells by direct contact with PD-1 on the surface of activated T cells (7) . However, information about how B reg cells are developed and maintained in peripheral tissues to regulate inflammatory diseases is very limited.
Mast cells (MCs) are essential cells for inducing immediate hypersensitivity (also known as type I hypersensitivity) through immunoglobulin E (IgE)-bound high-affinity Fc epsilon Receptor I (FcRI) signaling (8) . When MCs are activated by antigen, preformed granules that contain histamine and other proinflammatory mediators, eicosanoids, and proinflammatory cytokines are released from MCs. Because of the sustained release of these mediators, MCs are also known to be the major effector cells in immediate-and delayed-type hypersensitivity. In particular, MCs are activated by antigen or various stimulants in the state of allergic diseases, such as atopic dermatitis, allergic rhinitis, asthma, and anaphylaxis, thereby increasing the severity of the disease (8) . On the contrary, recent studies have shown some interesting results regarding the inhibitory role of MCs in hypersensitivity-related immune responses. We and others reported that MCs increase the population of IL-10-producing B reg cells in vitro and in vivo (9, 10) . In the type I hypersensitivity immune response, the CD40 ligand of MCs stimulates B reg cell development by interacting with CD40 of CD5 + B-1a cells as a negative regulatory mechanism of MCs (9) . However, the mechanism of IL-10 + B reg cell development by MCs in peripheral tissues has not been established.
CHS is a representative type of T H 1 immunity-associated allergic skin inflammation. The process of CHS is divided into two distinct phases. During sensitization, haptens are taken up by APCs, such as Langerhans cells and dermal dendritic cells. In the draining lymph node (LN), migrating APCs activate antigen-specific T cells (11) . It has been reported that CD1d + APCs, IL-4-producing natural killer T cells, and IgM from peritoneal B-1 cells also participate in the sensitization phase (12) . In the elicitation phase, the hapten-specific T cells migrate to the inflammatory site. These cells release various proinflammatory cytokines and chemokines, leading to leukocyte infiltration. Overall, although hapten-induced T H 1 responses are predominant, T H 2 mediators are also activated during the response and contribute substantially to the pathology of CHS (12) . Repeated challenges with OXZ in mice result in chronic allergic inflammatory responses similar to those observed in human atopic dermatitis, such as barrier disruption, T H 2 cell-predominant inflammation, and hyper-infiltration of other effector cells, such as MCs and eosinophils (13) . However, some studies have unexpectedly presented results regarding the inhibitory role of MCs in CHS (14) (15) (16) (17) . In severe CHS, MCs suppress the development of skin inflammation through the secretion of IL-10 (14, 17) or through the expansion of T reg cells by IL-2 released from MCs (15) . These studies further suggest that there exists another regulatory mechanism that remains to be clear.
The group 2 innate lymphoid cells (ILC2s) have emerged as potent effector cells in various allergic diseases, including skin inflammation. Similar to T H 2 cells, ILC2s secrete type 2 cytokines, such as IL-4, IL-5, and IL-13. These cells are known to be involved in initial host defense and parasitic infection, but recent studies have shown that they also play a critical role in causing allergic symptoms in atopic dermatitis and allergic asthma (18) . In particular, IL-13 is known to play a key role in skin fibrosis and epithelial disruption, and ILC2s have further been demonstrated to be a major source of IL-13 in skin pathology (19) . Although many studies on the function of ILC2s have been reported in hypersensitivity-related skin inflammation, including atopic dermatitis, little is known about the regulation of ILC2s in peripheral tissues.
In this study, we demonstrate that IL-10 + B reg cells suppress IL-13 + ILC2s to inhibit CHS in an IL-10-dependent manner. Furthermore, MC IL-5 is important for the maintenance of IL-10 + B reg cells in peripheral lymphoid tissues.
RESULTS

Population changes in MCs, ILC2s, and B reg cells in lymphoid tissues of mice with oxazolone-induced CHS
To analyze the alterations of various immune cells in CHS, we induced severe CHS by oxazolone (OXZ) in mice (Fig. 1, A and B ) and examined the distributions of MCs, ILC2s, and IL-10 + B reg cells in spleen, axillary LN (aLN), inguinal LN (iLN), peritoneal cavity (PeC), and ear ( Fig. 1) . The populations of immune cells, such as CD4 + T cells, neutrophils, monocytes/macrophages, and dendritic cells, that are responsible for local inflammation increased mostly in the draining LNs and ear tissue of CHS mice ( fig. S1 ). MCs were frequently detected in the LNs and ear tissue but rarely detected in the spleen (Fig. 1C) . While the number of MCs in the LNs was decreased by the induction of CHS, MCs were increased in the ear tissue (Fig. 1D) . The number of IL-13 + ILC2s was increased in the spleen, LNs, and ear tissue during CHS (Fig. 1, E and F) , suggesting the possibility that IL-13 + ILC2s are also associated with the pathology of OXZ-induced CHS. We further observed that the number of IL-10 + B reg cells was also increased in the spleen and LNs but not in the PeC (Fig. 1, G and H) . In some allergic diseases, such as casein-induced food allergy, the inhibitory effect of IL-10 + B reg cells is T reg cell dependent (20 
CD5
+ B cell subsets was accordingly increased in the LNs but not in the spleen and PeC in CHS mice (Fig. 1, I and J). We further observed that the changes in immune cell populations were similar in mice with chronic atopic dermatitis-like symptom induced by OXZ ( fig. S3 ). These results led us to conduct a study of the cross-talk among MCs, IL-10 + B reg cells, and IL-13 + ILC2s in peripheral lymphoid tissues during CHS.
The suppressive effect of B reg cells on IL-13 + ILC2s is independent of T reg cells but dependent on IL-10
In our previous study, we reported that IL-10 + B reg cells inhibit MC activity in mice with IgE-mediated anaphylaxis (9). Yanaba and co-workers reported that CHS is exacerbated in CD19-deficient mice, in which IL-10 + B reg cells are mostly depleted (21) . Notably, the symptoms were more severe in CD19-deficient mice than in wild-type (WT) mice ( Fig. 2A) OXZ-induced CHS is generally accepted as a T cell-dependent response (22) . To eliminate the roles of effector and T reg cells in OXZinduced CHS mice, we next used Rag2 −/− mice in which B cells and T cells are mostly depleted (23) . However, the IL-13 + ILC2 population was still intact (Fig. 2E) , and OXZ-induced CHS was evident in Rag2 −/− mice (Fig. 2F) , indicating that the OXZ-induced CHS response is induced in the absence of T cells. When total ILCs were depleted by the administration of a Thy1.2 monoclonal antibody (mAb) in Rag2 −/− mice, the CHS response induced by OXZ was significantly suppressed (Fig. 2, F and G) . Furthermore, the response was significantly reduced when we administered anti-IL-13 antibody into OXZinduced CHS mice ( fig. S5) (Fig. 2, K and L) . These results further suggest that B reg cell-derived IL-10 inhibits the activation of ILC2s to secrete IL-13 in OXZ-induced CHS mice.
MCs are critical for the enhancement of IL-10 + B reg cells in peripheral tissues
In some previous studies, MCs were reported as negative regulators of CHS disease. The production of IL-10 by dermal MCs contributes to the anti-inflammatory effects of MCs in allergic contact dermatitis (14) .
It was also reported that MC-derived IL-2 contributes to the suppression of chronic allergic skin inflammation via the induction of Foxp3 + T reg cells (15) . MCs also stimulate the expansion and differentiation of IL-10 + B reg cells in colitis (10) and IgE-mediated anaphylaxis (9). However, it remains totally unclear how MCs stimulate the IL-10 + B reg cell population. We observed that the CHS response was markedly increased in MC-deficient Kit W-sh/W-sh mice compared to that in WT mice (Fig. 3, A and B) . Notably, the frequency and number of IL-10 + B reg cells were significantly reduced in the spleen, aLN, iLN, and PeC in MC-deficient Kit W-sh/W-sh mice (Fig. 3 , C and D), but no significant changes in the total B cell population were observed in the spleen, aLN, iLN, or PeC ( fig. S6A ). In the comparative experiment of WT and Kit W-sh/W-sh mice, the expressions of surface proteins from splenic B cells were not changed, if any, marginally changed, but those from PeC showed some changes ( fig. S6B ). We and other researchers have assumed that these changes have occurred because of the high proportion, approximately 40%, of IL-10 + B-1a cell population in PeC B cells (21) . Notably, there was no change in the serum concentration ILC2s have been reported to be a type of effector cell in skin inflammatory disorders, including atopic dermatitis (19, 24) . In our study, (Fig. 4D) . Suppression of the CHS response was observed only when MCs were reconstituted intravenously but not intraperitoneally ( fig.  4D ), suggesting that the restoration of IL-10 + B reg cells in the LNs or spleen, but not PeC, by MCs plays a critical role in the suppression of the CHS response (Fig. 4E) . Notably, the number of IL13 + ILC2s was suppressed in the LNs and ear tissue of MC-reconstituted mice compared to that in MC-deficient Kit W-sh/W-sh mice (Fig. 4F) . These results suggest that a unique cross-talk among MCs, IL-10 + B reg cells, and IL-13 + ILC2s could occur most possibly in the draining LNs. show the amount of IL-13 by enzyme-linked immunosorbent assay (ELISA). (D to F) Data are expressed as the mean ± SEM from two independent experiments (n ≥ 3 per group for each experiment). *P < 0.05; **P < 0.01; n.s., not significant by one-way ANOVA with post hoc Tukey's test.
MC-derived IL-5 is critical for IL-10
+ B reg cell development It was reported that MCs enhance the population of IL-10 + B reg cells in IgE-mediated anaphylaxis and colitis through the interaction of CD40 (on B cells) and CD40L (on MCs) (9, 10 (Fig. 5A) . Furthermore, IL-5 increased the population of IL-10 + B reg cells and IL-10 secretion from CD19 + B cells (Fig. 5B) . Previously, it was reported that IL-4 stimulated the expression of IL-5 receptors in B cells (25) . We also examined the expression of the IL-5 receptor, which was significantly increased by IL-4 ( Although the knowledge about the differentiation process of B reg cells is very limited at present, IL-10 + B reg cells are known to be the most abundant of the CD5 + B cell subsets, at least in mice (26) . Furthermore, we found that MCs are critical for the development of CD5 + B cells (Fig. 4B) . Next, we analyzed what type of CD5 + B cell subset was promoted by IL-5. IL-5 increased the expression of CD5 on CD19 + B cells (Fig. 5E) . Furthermore, the simultaneous treatment with IL-4 and IL-5 synergistically increased the expression of CD5 (Fig. 5E) . Yanaba et al. (21) (Fig. 5, F and G S9, A and B) . We further found out that the OXZ-induced CHS response was more severe in Il5ra −/− mice than in WT mice (Fig. 6H) (Fig. 6J) . Altogether, these results suggest that MC IL-5 is critical for maintaining IL-10 + B reg cells in peripheral lymphoid tissues.
DISCUSSION
In this study, we observed that the skin inflammation response induced by OXZ was much more severe in Kit W-sh/W-sh mice with CHS than in WT mice (Fig. 3A) . However, when MCs were reconstituted intravenously in Kit W-sh/W-sh mice, CHS symptoms were alleviated to the level of WT mice (Fig. 4D) . These results suggest that MCs are suppressive cells for skin inflammation in mice with hapten-induced CHS and chronic atopic dermatitis-like symptoms. We are also aware of the other abnormalities of MC-deficient Kit W-sh/W-sh mice caused by the lack of Kit (28) (29) (30) (31) . To overcome such a drawback, we carried out experiments by transferring various genetically modified or WT MCs (Fig. 6) . Dudeck et al. reported some evidence that MCs amplify rather than limit CHS responses. They argued that the exaggerated CHS reactions, observed in Kit-mutant animals, are not caused by the absence of MCs but instead reflect other effects of the Kit deficiency (32) . By contrast, Gimenez-Rivera et al. (16) and Reber et al. (17) recently reported that MCs suppress skin inflammation in severe CHS based on findings in both Kit-mutant and Kit-independent MC-deficient mice. Furthermore, Reber et al. (17) have clearly shown that this controversy is due to the difference in the severity of CHS. Therefore, it is largely plausible that MCs function as a stimulator in mild CHS (32) or as a suppressor in severe CHS (Fig. 3A) (16, 17) . In this study, B reg cells were not fully recovered to the level of WT mice when MCs were reconstituted into Kit W-sh/W-sh mice, especially in PeC (Fig. 4E) . Although our results demonstrated that MCs suppress the OXZ-induced severe CHS via the IL-10 + B reg cells, the possibility that Kit-dependent abnormalities of MCs would partially affect the regulator role of MCs should be considered.
MCs secrete a variety of biologically active substances, including many types of cytokines and chemokines (8) . Recently, it was reported that MC IL-2 is helpful in stimulating the population of Foxp3 + T reg cells to suppress OXZ-induced skin inflammation (15) . In Kit W-sh/W-sh mice, the IL-10 + B reg cell population was markedly decreased (Fig. 3, C and D (Fig. 3, C and D (Fig. 5A) . These results suggest that MCs play an important role in maintaining a constant amount of IL-5 in the LNs. In addition, the IL-10 + B reg cell population was increased by IL-5 stimulation in CD19 + B cells (Fig. 5B ). Our results (Fig. 5C ) and a previous report indicated that IL-4 increases the expression of the IL-5 receptor (CD125) on B cells (25) . When CD19 + B cells were treated with IL-4 and IL-5 simultaneously, the population of IL-10 + B reg cells was synergistically increased (Fig. 5D) . Altogether, our results suggest that MCs are important for maintaining a constant level of IL-5 to maintain the homeostasis of IL-10 + B reg cells in peripheral lymphoid tissues, especially in the LNs.
ILC2s have been reported to be critical effector cells in skin inflammation, including atopic dermatitis (19, 24) . We also observed that skin inflammation was significantly suppressed by the removal of all types of ILCs using a Thy1.2 mAb in Rag2 −/− mice (Fig. 2E) , suggesting that ILCs, most likely ILC2s, are the critical effector cells in OXZ-induced CHS. It has been well documented that IL-13 is critically associated with a variety of types of skin inflammation, and ILC2s are a major source of IL-13 in skin pathology (19) . On the basis of our results and previous reports, we hypothesized that the aggravation of OXZ-induced CHS in Kit W-sh/W-sh mice was caused by the decrease in the IL-10 + B reg cell population and the subsequent reduced suppression of IL-13 + ILC2s. We further observed that the transfer of MCs into Kit W-sh/W-sh mice restored the IL-10 + B reg cell population to the level of WT mice (Fig. 4) WT mice, and IL-10 + B reg cells were restored in the PeC only when PeC-derived MCs were transferred into the PeC (Fig. 4, B and E) . Furthermore, OXZ-induced CHS was worse in Kit W-sh/W-sh mice than in WT mice, but the symptoms were greatly relieved by MC reconstitution via intravenous but not via intraperitoneal administration (Fig. 4D) . In particular, we found that IL- (Fig. 2, I and J), but we did not observe the migration of IL-10 + B reg cells to the ear tissue (Fig. 2H) . These results suggest that the lymphoid tissue in which IL-10 + B reg cells regulate IL-13 + ILC2s is the LNs. Notably, the population of IL-13 + ILC2s and the amount of IL-13 were significantly increased in the LNs and ear tissue of Kit W-sh/W-sh mice compared to those in WT mice (Fig. 3, E and F) . We further observed that the CHS symptom was significantly suppressed when anti-IL-13 antibody was administered in the OXZ-induced mice with CHS ( fig. S5 ). Collectively, it seems very likely that these elevated levels of IL-13 and IL-13 + ILC2s are the cause of worsening CHS symptoms. We further observed that the population of IL-13 + ILC2s was greatly suppressed by reconstituting MCs in Kit W-sh/W-sh mice (Fig. 4F) . Further, in vitro studies also demonstrated that B reg cells suppressed the population of IL-13 + ILC2s in an IL-10-dependent manner (Fig. 2, K + B cell subset (27) . We observed that the adoptive transfer of MCs into Kit W-sh/W-sh mice increased the CD5 + B cell subset population (Fig. 4C) . In addition, treatment with IL-5 increased the expression of CD5 in B cells (Fig. 5E ). Consistent with these findings, the population of the CD1d int CD5 + B cell subset was significantly reduced in the peripheral lymphoid tissues of Il5ra −/− mice (Fig. 5, G and H) . Furthermore, in coculture experiments of WT MCs and B cells, the increase in the IL-10 + B reg cell population by MCs was inhibited by blocking IL-5 signaling with an anti-IL-5 receptor antibody (Fig. 6, A and B) . In addition, the increase in the IL-10 + B reg cell population was not observed in coculture experiments of Il5r −/− B cells + WT MCs (Fig. 6C) or WT B cells + Il5 v/v MCs (Fig. 6D) (Fig. 6G) . We also observed that the transfer of (Fig. 6, I and J). Together, these results indicate that MC IL-5 has no effect or minor effects on the population of CD1d The mechanism of immune tolerance is critical for protecting the healthy body from abnormal and excessive immune responses. The destruction of immune tolerance may lead to autoimmune or allergic diseases (34) . It is generally accepted that there are two pivotal mechanisms for obtaining central and peripheral immune tolerance. The mechanism of central tolerance is defined by the removal of lymphocytes that respond to autoantigens called negative selection, when lymphocytes are developed in the bone marrow and thymus (35) . When mature immune cells that pass central tolerance migrate to the peripheral tissues, immune cells that respond to autoantigens presented in the peripheral tissues are removed or inactivated by the mechanism of peripheral immune tolerance (36) . Peripheral immune tolerance is developed in peripheral lymphoid tissues by intrinsic anergy and apoptosis of lymphocytes or by extrinsic regulatory immune cells, such as Foxp3 + T reg cells (37) . At present, the mechanism of central tolerance is relatively well established, whereas information about the mechanism that underlies peripheral immune tolerance is very limited. (Fig. 6) . However, studies on whether MC IL-5 has the same regulatory effect in CHS animal models induced by other haptens remain to be clear. For example, it was recently reported that MCs suppress the development of some severe CHS responses induced by 2,4-dinitrofluorobenzene (DNFB) by themselves producing IL-10, especially at early intervals after induction of the CHS (17) . They also suggested that there would be other mechanisms besides the mechanism that MCs secrete IL-10. On the basis of their results and our present results, it is possible that the MC production of both IL-10 and IL-5 has a cooperative role in regulating the severity of CHS by various haptens, including DNFB and OXZ.
In summary, we demonstrate that MC IL-5 is important for maintaining the homeostasis of IL-10 + B reg cells in peripheral lymphoid tissues in OXZ-induced severe CHS. The B reg cells inhibit IL-13 + ILC2s to suppress skin inflammation in an IL-10-dependent manner.
MATERIALS AND METHODS
Mice
WT (6-to 10-week-old male C57BL/6 mice), Cd19
Cre (CD19 deficient),
−/− , and Kit W-sh/W-sh mice on the C57BL/6 background were purchased from The Jackson Laboratory (Bar Harbor, ME). Il5ra −/− (C57BL/6 background) mice were obtained from the RIKEN BioResource Center (Tsukuba, Japan). Il5 V/V knockin (C57BL/6 background; IL-5 deficient) mice were provided by S. Takaki (Department of Immune Regulation, Research Institute, National Center for Global Health and Medicine, Chiba, Japan), and the mice were generated as previously described (38) . The mice were housed in a pathogen-free facility at Konkuk University (Seoul, Korea).
Induction of a CHS mouse model
CHS was induced according to a previously reported method (21) . Briefly, the mice were sensitized with 25 l of OXZ (100 mg/ml; Sigma-Aldrich, St. Louis, MO) in acetone/olive oil (4:1, v/v) on the shaved hind flank for two consecutive days. Five days later, the mice were challenged by the application of 10 l of OXZ (10 mg/ml) in acetone/olive oil (4:1, v/v) on the ear. Ear thickness was measured by two blinded independent observers. Two days after the mice were challenged with OXZ, the lymphoid tissues were isolated and used for flow cytometric analysis or enzyme-linked immunosorbent assay (ELISA).
In vivo antibody-based neutralization
To deplete ILCs in vivo, the Rag2 −/− mice were injected intraperitoneally with 200 g of an anti-Thy1.2 mAb (30H12, Bio X Cell, West Lebanon, NH) or isotype-matched control mAb three times on day −5 (sensitization), day −2 (before challenge), and day 1 (after challenge). For the depletion of T reg cells, the Cd19
Cre mice were also injected intraperitoneally with 250 g of anti-CD25 mAb (PC61, Bio X Cell, West Lebanon, NH) or an isotype-matched control mAb twice on day −5 (sensitization) and day −1 (before challenge). To deplete IL-13, C57BL/6 mice were injected with 200 g of anti-IL-13 mAb (8H8, InvivoGen, San Diego, CA) or an isotype-matched control mAb through the lateral tail vein twice on day −1 (before challenge) and day 0 (1 hour before challenge).
Histological analysis and immunofluorescence
After the induction of CHS, the fixed [4% paraformaldehyde in phosphate-buffered saline (PBS)] ear tissues were dehydrated in a graded ethanol series (70 to 100%), rinsed three times with xylene for 3 min each, and then embedded in paraffin. The 5-m paraffin sections were stained with hematoxylin and eosin (H&E). MCs in the lymphoid tissues (e.g., spleen, aLN, and iLN) or ear tissues were histologically examined, as described previously (9) . The number of MCs in each tissue was measured by toluidine blue staining. To determine IL-10 + B cells in tissues, the tissue sections were blocked with 10% normal horse serum for 1 hour and then stained with anti-IL-10 (1 g/ml; A-2, Santa Cruz Biotechnology, Dallas, TX), anti-CD19 (1 g/ml; eBio1D3, eBioscience, San Diego, CA), or B220-eFluor 570 (1 g/ml; RA3-6B2, eBioscience) antibodies or isotype controls. After washing with PBS, the sections were incubated with fluorescein isothiocyanate-conjugated anti-mouse or anti-rat antibodies and then counterstained with 4′,6′-diamidino-2-phenylindole. After mounting, fluorescence images were obtained using an FV-1000 laser scanning inverted confocal microscope (Olympus, Tokyo, Japan). W-sh/W-sh mice, bone marrow-derived MCs (BMMCs) from isolated C57BL/6 mice were cultured in complete RPMI 1640 medium containing IL-3 (10 ng/ml; PeproTech Inc., Rock Hill, NJ) for 4 weeks, following the published procedure (39) . PeC-derived MCs (PDMCs) were cultured in complete RPMI 1640 medium containing IL-3 (10 ng/ml) and stem cell factor (30 ng/ml; PeproTech Inc., Rock Hill, NJ). After 48 hours, nonadherent cells were removed and replaced by the fresh complete medium for 9 days (40 ) cells, the cells were stimulated with PMA (50 ng/ml; Sigma-Aldrich), ionomycin (500 ng/ml; Sigma), and brefeldin A (3 g/ml; eBioscience) for 4 hours before analysis. The cells were then analyzed with a FACSCanto II flow cytometer (BD Bioscience) and FlowJo version 10 software (Tree Star, Ashland, OR).
Preparation of B cell subsets
Measurement of cytokines and Igs
Proteins from the peripheral tissues (e.g., spleen, aLN, iLN, and ear) of mice were isolated with 500 l of complete extraction buffer (Abcam, Cambridge, MA) with homogenization. The level of cytokines was measured by using a mouse BD OptEIA ELISA kit according to the manufacturer's instructions (BD Biosciences, San Jose, CA). In some experiments, isolated splenic CD19 + B cells were stimulated with recombinant mouse IL-5 (10 ng/ml; PeproTech Inc., Rock Hill, NJ) for 48 hours The level of IL-10 was assessed by using ELISA kits from BD Biosciences. The serum concentrations of IgG1, IgG2a, IgA, or IgE were measured using sandwich ELISAs (MaxiSorp, Nunc, Roskilde, Denmark). Briefly, a microtiter plate was coated with each Ig-specific capture antibody (BD Biosciences) overnight at 4°C. The plates were blocked with PBS buffer (pH 7.0) containing 10% fetal bovine serum. Sera were added to the wells and incubated at room temperature (RT) for 2 hours. The wells were washed and incubated with 2 g of biotin-labeled rat anti-mouse IgG1, IgG2a, IgA, or IgE (BD Biosciences) at RT for 1 hour. The supernatants were aspirated, and the wells were washed three times with a blocking buffer. The plates were incubated with a solution of streptavidin-horseradish peroxidase (BD Biosciences) at RT for 30 min. After washing out the solution, the plates were developed using a tetramethylbenzidine substrate solution (GenDEPOT, Barker, TX) and read at 450 nm.
In vitro coculture of B cells with MCs or ILC2s
Mouse B cells were isolated from splenocytes with CD19 mAbmicrobeads (Miltenyi Biotec). Bone marrow-derived ILC2s were negatively selected by hematopoietic lineage cocktail mAb-microbeads (Miltenyi Biotec), and the cells were then incubated with IL-2, IL-25, and IL-33 (10 ng/ml) at 37°C for 72 hours. 
Statistical analysis
The data are presented as the mean ± SEM from three or more independent experiments for in vitro experiments. All animal experiments were performed with five or more mice per group in each experiment. Statistical analysis was done by Student's t test or the Mann-Whitney test. One-way analysis of variance (ANOVA) with Tukey's post hoc test was performed for comparisons among multiple experimental groups. Statistical analysis (*P < 0.05 and **P < 0.01) was carried out with SigmaStat software version 12 (Systat Software, Inc., Point Richmond, CA).
Study approval
All animal experiments were approved by the Institutional Animal Care and Use Committee of Konkuk University.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/5/7/eaav8152/DC1 Fig. S1 . Leukocyte population changes in mice with OXZ-induced CHS. 
